PREVISQCOR: Survey on Practice and Comparison With Best Evidence in Surgical Site Infection Prevention in Colorectal Surgery

Sponsor
Hospital de Granollers (Other)
Overall Status
Completed
CT.gov ID
NCT03883399
Collaborator
(none)
355
1
8.9
39.9

Study Details

Study Description

Brief Summary

Web-based survey to colorectal surgeons assessing knowledge, beliefs and practices regarding the use of preventative measures for SSI.

Condition or Disease Intervention/Treatment Phase
  • Other: Survey

Detailed Description

A web-based survey (SurveyMonkey©; https://es.surveymonkey.com/r/FBVR59C) to the members of the Colorectal Chapter of the Spanish Association of Surgeons (AEC) and the Spanish Association of Coloproctology (AECP). A link to the web page containing the survey is disseminated via email, newsletter and Twitter.

A board from the Surgical Infection Section did a review of evidence and previous guidelines to be used in the evaluation of the results. The most recent clinical practice guidelines have been analysed. Furthermore, an extensive review of specific measures for colorectal surgery has been published and used for evaluation. According to the review, the preventive measures analysed in the survey have been distributed into two groups: high or low level of evidence.

The survey aim to assess knowledge, beliefs, and practices of attending colorectal surgeons on preventative measures including mechanical bowel preparation (MBP), oral antibiotic prophylaxis and the use of drains. Furthermore, the questions address the level of accordance between their beliefs and the protocols or the usual practice of their units. The agreement rate between the beliefs and usual practice of all respondents will be calculated on a scale from 0 to 100. For discussion, the responses on the implementation of major surgical site infection (SSI) prevention measures will be compared with the recommendations of the expert group. Other questions are related to the types of complications that surgeons believe are prevented by the use of oral antibiotic prophylaxis or MBP, reasons for not using either of them, type of oral and systemic antibiotics and cathartics used, and strategies already in place or that should be implemented to reduce SSI rates at respondents' hospitals.

The results will be expressed in percentages on the total answers obtained. Responses will be entered into a computerized database that will be analysed using the SPSS program (v.10.0, Chicago, IL, USA). The results will be analysed using the chi-square test with statistical significance defined as p <0.05.

Study Design

Study Type:
Observational
Actual Enrollment :
355 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Awareness of Practice and Comparison With Best Evidence in Surgical Site Infection Prevention in Colorectal Surgery
Actual Study Start Date :
Nov 1, 2018
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Jul 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Colorectal surgeons

Survey among Spanish colorectal surgeons

Other: Survey
Survey among colorectal surgeons

Outcome Measures

Primary Outcome Measures

  1. Awareness of practice - Percentage of responders who use each preventive measures for surgical site infection [2019]

    Percentage of responders who use each preventive measures for surgical site infection (including mechanical bowel preparation and oral antibiotic prophylaxis), compared to their beliefs and knowledge of scientific evidence.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Colorectal surgeons members of the Colorectal Chapter of the Spanish Association of Surgeons (AEC) and the Spanish Association of Coloproctology (AECP)
Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fundació Privada Hospital Asil de Granollers Granollers Barcelona Spain 08402

Sponsors and Collaborators

  • Hospital de Granollers

Investigators

  • Principal Investigator: Josep M Badia, Universitat Internacional de Catalunya

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Josep Maria Badia, Prof, Hospital de Granollers
ClinicalTrials.gov Identifier:
NCT03883399
Other Study ID Numbers:
  • PREVISQCOR-19
First Posted:
Mar 20, 2019
Last Update Posted:
Oct 9, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Josep Maria Badia, Prof, Hospital de Granollers
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 9, 2019